Valuation: MindMaze Therapeutics Holding SA

Market Cap 24.29M 30.16M 25.88M 22.19M 41.88M 2.88B 42.08M 288M 111M 1.45B 113M 111M 4.81B P/E 2026 *
-3.98x
P/E 2027 * 1.14x
Enterprise Value 15.88M 19.71M 16.91M 14.5M 27.36M 1.88B 27.5M 188M 72.81M 948M 73.99M 72.38M 3.14B EV / Sales 2026 *
2.69x
EV / Sales 2027 * 0.12x
Free-Float
38.51%
Yield 2026 *
-
Yield 2027 * -
1 day-1.38%
1 week-25.28%
Current month-21.79%
1 month-13.44%
3 months-61.77%
6 months-78.83%
Current year-91.80%
1 week 0.15
Extreme 0.1486
0.22
1 month 0.15
Extreme 0.1486
0.28
Current year 0.15
Extreme 0.1486
1.87
1 year 0.15
Extreme 0.1486
2.92
3 years 0.15
Extreme 0.1486
2.92
5 years 0.15
Extreme 0.1486
2.92
10 years 0.15
Extreme 0.1486
2.92
Date Insider Type Main position Quantity % Market Cap.
12/19/25 A Sell 140,000 0.0908%
12/19/25 A Sell 52,162 0.0338%
12/19/25 A Sell 281,968 0.1830%
Change 5-day change 1-year change 3-year change Capi.($)
-2.14%-25.28% - - 30.26M
-1.01%+1.48%+1.66%+23.62% 51.65B
-0.03%-0.38%+473.67%+562.85% 45.31B
+0.91%+4.90%+39.27%+17.90% 42.7B
-0.52%-0.42%+21.48%+85.69% 42.79B
-2.27%-3.02%+14.22%+51.50% 32.87B
+0.89%+1.82%+31.97%+136.70% 17.14B
-1.02%-3.39% - - 16.61B
-1.70%+3.06%+11.11%+28.57% 15.01B
-0.30%+2.25%+81.13%+49.18% 14.21B
Average -0.64%+0.44%+84.31%+119.50% 27.83B
Weighted average by Cap. -0.51%+2.74%+101.18%+138.78%

Financials

2026 *2027 *
Net sales 5.9M 7.32M 6.29M 5.39M 10.17M 699M 10.22M 69.82M 27.06M 352M 27.5M 26.9M 1.17B 43.2M 53.62M 46.03M 39.46M 74.46M 5.11B 74.82M 511M 198M 2.58B 201M 197M 8.55B
Net income -7.81M -9.7M -8.32M -7.13M -13.46M -925M -13.53M -92.44M -35.82M -467M -36.41M -35.61M -1.55B 24.83M 30.82M 26.45M 22.68M 42.79M 2.94B 43M 294M 114M 1.48B 116M 113M 4.91B
Net Debt -8.42M -10.45M -8.97M -7.69M -14.51M -997M -14.58M -99.63M -38.61M -503M -39.24M -38.39M -1.67B -19.27M -23.92M -20.53M -17.6M -33.21M -2.28B -33.37M -228M -88.37M -1.15B -89.81M -87.86M -3.81B
Logo MindMaze Therapeutics Holding SA
MindMaze Therapeutics Holding SA, formerly known as RELIEF THERAPEUTICS Holding SA, is a Switzerland-based company that engages in research, development, production, and sale of biotechnology, pharmaceutical, diagnostic, therapeutic, chemical, and cosmetic products. The Company acquires and manages patents, licenses, and intellectual property, provides preclinical, clinical, and regulatory services, and may establish subsidiaries worldwide. The Company also participates in the acquisition, holding, and financing of interests in companies, offers management services to affiliates, and develops scientific and economic solutions for disease treatment and therapeutic approaches. Additionally, the Company may acquire, hold, and sell trademarks and other IP rights globally, and provide or obtain financing through loans or guarantees to support its corporate purpose.
Employees
-
Date Price Change Volume
26/08/26 CHF 0.1558 -2.14% 2,182,916
25/08/26 CHF 0.1592 -4.56% 2,059,936
24/08/26 CHF 0.1668 -12.21% 2,333,343
21/08/26 CHF 0.1900 +0.11% 1,113,425
20/08/26 CHF 0.1898 -8.97% 1,821,062
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Annual profits - Rate of surprise